Choreo LLC’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.13M | Buy |
182,908
+17,634
| +11% | +$469K | 0.06% | 214 |
|
|
2025
Q4 | $4.13M | Sell |
165,274
-9,814
| -6% | -$247K | 0.05% | 225 |
|
|
2025
Q3 | $4.46M | Sell |
175,088
-6,375
| -4% | -$157K | 0.06% | 216 |
|
|
2025
Q2 | $4.4M | Buy |
181,463
+5,664
| +3% | +$132K | 0.06% | 215 |
|
|
2025
Q1 | $4.45M | Buy |
175,799
+6,471
| +4% | +$169K | 0.07% | 199 |
|
|
2024
Q4 | $4.49M | Sell |
169,328
-55,859
| -25% | -$1.52M | 0.06% | 208 |
|
|
2024
Q3 | $6.46M | Buy |
225,187
+41,485
| +23% | +$1.21M | 0.09% | 149 |
|
|
2024
Q2 | $5.18M | Buy |
183,702
+77,645
| +73% | +$2.14M | 0.09% | 155 |
|
|
2024
Q1 | $2.94M | Sell |
106,057
-13,516
| -11% | -$375K | 0.08% | 140 |
|
|
2023
Q4 | $3.44M | Buy |
119,573
+12,181
| +11% | +$368K | 0.09% | 129 |
|
|
2023
Q3 | $3.56M | Buy |
107,392
+4,024
| +4% | +$142K | 0.13% | 96 |
|
|
2023
Q2 | $3.79M | Sell |
103,368
-8,803
| -8% | -$343K | 0.13% | 100 |
|
|
2023
Q1 | $4.58M | Buy |
112,171
+88,547
| +375% | +$3.82M | 0.16% | 92 |
|
|
2022
Q4 | $1.21M | Sell |
23,624
-452
| -2% | -$21.7K | 0.06% | 88 |
|
|
2022
Q3 | $1.05M | Buy |
24,076
+288
| +1% | +$14K | 0.06% | 88 |
|
|
2022
Q2 | $1.25M | Buy |
23,788
+610
| +3% | +$31.1K | 0.07% | 78 |
|
|
2022
Q1 | $1.2M | Buy |
23,178
+3
| +0% | +$156 | 0.06% | 86 |
|
|
2021
Q4 | $1.37M | Buy |
23,175
+174
| +0.8% | +$8.62K | 0.07% | 74 |
|
|
2021
Q3 | $989K | Buy |
23,001
+1,327
| +6% | +$58.8K | 0.05% | 97 |
|
|
2021
Q2 | $849K | Sell |
21,674
-457
| -2% | -$17.8K | 0.05% | 101 |
|
|
2021
Q1 | $802K | Sell |
22,131
-1,942
| -8% | -$69K | 0.05% | 93 |
|
|
2020
Q4 | $886K | Sell |
24,073
-492
| -2% | -$18K | 0.06% | 84 |
|
|
2020
Q3 | $855K | Sell |
24,565
-2,434
| -9% | -$85.3K | 0.07% | 80 |
|
|
2020
Q2 | $838K | Sell |
26,999
-5,329
| -16% | -$181K | 0.08% | 78 |
|
|
2020
Q1 | $1M | Sell |
32,328
-2,122
| -6% | -$72.3K | 0.12% | 68 |
|
|
2019
Q4 | $1.28M | Buy |
34,450
+3,354
| +11% | +$119K | 0.13% | 76 |
|
|
2019
Q3 | $1.06M | Sell |
31,096
-6,432
| -17% | -$234K | 0.12% | 79 |
|
|
2019
Q2 | $1.54M | Sell |
37,528
-9,303
| -20% | -$369K | 0.18% | 55 |
|
|
2019
Q1 | $1.89M | Sell |
46,831
-1,919
| -4% | -$76.9K | 0.23% | 46 |
|
|
2018
Q4 | $2.02M | Sell |
48,750
-2,689
| -5% | -$112K | 0.29% | 44 |
|
|
2018
Q3 | $2.15M | Sell |
51,439
-14,718
| -22% | -$567K | 0.28% | 46 |
|
|
2018
Q2 | $2.28M | Sell |
66,157
-2,576
| -4% | -$88K | 0.31% | 49 |
|
|
2018
Q1 | $2.31M | Buy |
68,733
+1,215
| +2% | +$41.8K | 0.28% | 55 |
|
|
2017
Q4 | $2.32M | Buy |
67,518
+3,221
| +5% | +$110K | 0.28% | 59 |
|
|
2017
Q3 | $2.18M | Buy |
64,297
+12,110
| +23% | +$389K | 0.29% | 55 |
|
|
2017
Q2 | $1.66M | Sell |
52,187
-6,756
| -11% | -$213K | 0.23% | 64 |
|
|
2017
Q1 | $1.91M | Sell |
58,943
-12,592
| -18% | -$397K | 0.28% | 60 |
|
|
2016
Q4 | $2.2M | Buy |
71,535
+5,336
| +8% | +$163K | 0.35% | 56 |
|
|
2016
Q3 | $2.13M | Buy |
66,199
+8,233
| +14% | +$275K | 0.37% | 48 |
|
|
2016
Q2 | $1.94M | Buy |
57,966
+4,640
| +9% | +$148K | 0.37% | 46 |
|
|
2016
Q1 | $1.5M | Buy |
53,326
+3,074
| +6% | +$87.8K | 0.3% | 48 |
|
|
2015
Q4 | $1.54M | Sell |
50,252
-840
| -2% | -$26.4K | 0.36% | 36 |
|
|
2015
Q3 | $1.52M | Buy |
51,092
+1,879
| +4% | +$60.2K | 0.4% | 34 |
|
|
2015
Q2 | $1.57M | Buy |
49,213
+7,308
| +17% | +$238K | 0.39% | 34 |
|
|
2015
Q1 | $1.38M | Sell |
41,905
-2,391
| -5% | -$76K | 0.35% | 38 |
|
|
2014
Q4 | $1.31M | Buy |
44,296
+1,682
| +4% | +$48.2K | 0.35% | 40 |
|
|
2014
Q3 | $1.2M | Buy |
42,614
+1,403
| +3% | +$39.4K | 0.35% | 42 |
|
|
2014
Q2 | $1.16M | Sell |
41,211
-410
| -1% | -$11.7K | 0.33% | 42 |
|
|
2014
Q1 | $1.27M | Buy |
+41,621
| New | +$1.24M | 0.37% | 37 |
|
Other funds holding PFE
VCM
VPM
Choreo LLC's PFE Position: Q1 2026 in Review
Choreo LLC increased its Pfizer (PFE) stake by 11% in Q1 2026, buying an estimated $469K and bringing the position to 182,908 shares worth $5.13M. The position accounts for 0.06% of the portfolio, ranked #214.
Choreo LLC first reported a position in PFE in Q1 2014 and has held it in 49 quarters since. The position peaked at $6.46M in Q3 2024. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Choreo LLC held 182,908 shares of Pfizer worth $5.13M as of Q1 2026.
- Choreo LLC bought 17,634 Pfizer shares in Q1 2026, an estimated $469K.
- Pfizer made up 0.06% of Choreo LLC's portfolio in Q1 2026, its #214 holding.
- Choreo LLC first reported a position in Pfizer in Q1 2014 and has held it in 49 quarters since.
- Choreo LLC's Pfizer position peaked at $6.46M in Q3 2024.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.